These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6402575)

  • 1. Oral administration of epsilon N-acetyllysine and homocitrulline in lysinuric protein intolerance.
    Rajantie J; Simell O; Perheentupa J
    J Pediatr; 1983 Mar; 102(3):388-90. PubMed ID: 6402575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance.
    Lukkarinen M; Näntö-Salonen K; Pulkki K; Aalto M; Simell O
    Metabolism; 2003 Jul; 52(7):935-8. PubMed ID: 12870174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term oral lysine supplementation in lysinuric protein intolerance.
    Tanner LM; Näntö-Salonen K; Niinikoski H; Huoponen K; Simell O
    Metabolism; 2007 Feb; 56(2):185-9. PubMed ID: 17224331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocitrullinuria and homoargininuria in lysinuric protein intolerance.
    Kato T; Sano M; Mizutani N
    J Inherit Metab Dis; 1989; 12(2):157-61. PubMed ID: 2474087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine deficiency in lysinuric protein intolerance: lysine-sparing effect of carnitine.
    Takada G; Goto A; Komatsu K; Goto R
    Tohoku J Exp Med; 1987 Dec; 153(4):331-4. PubMed ID: 3126568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperexcretion of homocitrulline in a Malaysian patient with lysinuric protein intolerance.
    Habib A; Md Yunus Z; Azize NA; Ch'ng GS; Ong WP; Chen BC; Hsu HT; Wong KJ; Pitt J; Ngu LH
    Eur J Pediatr; 2013 Sep; 172(9):1277-81. PubMed ID: 23358709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basolateral-membrane transport defect for lysine in lysinuric protein intolerance.
    Rajantie J; Simell O; Perheentupa J
    Lancet; 1980 Jun; 1(8180):1219-21. PubMed ID: 6104037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of urea cycle intermediates in lysinuric protein intolerance: effect on plasma and urinary arginine and ornithine.
    Rajantie J; Simell O; Perheentupa J
    Metabolism; 1983 Jan; 32(1):49-51. PubMed ID: 6401349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of arginine and citrulline in the treatment of lysinuric protein intolerance.
    Mizutani N; Kato T; Maehara M; Watanabe K; Ban M
    Tohoku J Exp Med; 1984 Jan; 142(1):15-24. PubMed ID: 6719441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysinuric protein intolerance: a two-year trial of dietary supplementation therapy with citrulline and lysine.
    Rajantie J; Simell O; Rapola J; Perheentupa J
    J Pediatr; 1980 Dec; 97(6):927-32. PubMed ID: 6777479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysinuric protein intolerance. Basolateral transport defect in renal tubuli.
    Rajantie J; Simell O; Perheentupa J
    J Clin Invest; 1981 Apr; 67(4):1078-82. PubMed ID: 7204568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-onset hepatic fibrosis in lysinuric protein intolerance.
    Shinawi M; Dietzen DJ; White FV; Sprietsma L; Weymann A
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):695-8. PubMed ID: 21716135
    [No Abstract]   [Full Text] [Related]  

  • 13. Lysinuric protein intolerance.
    Simell O; Perheentupa J; Rapola J; Visakorpi JK; Eskelin LE
    Am J Med; 1975 Aug; 59(2):229-40. PubMed ID: 1155480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced nitric oxide production by L-arginine deficiency in lysinuric protein intolerance exacerbates intravascular coagulation.
    Kayanoki Y; Kawata S; Yamasaki E; Kiso S; Inoue S; Tamura S; Taniguchi N; Matsuzawa Y
    Metabolism; 1999 Sep; 48(9):1136-40. PubMed ID: 10484053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Basolateral" and mitochondrial membrane transport defect in the hepatocytes in lysinuric protein intolerance.
    Rajantie J; Simell O; Perheentupa J
    Acta Paediatr Scand; 1983 Jan; 72(1):65-70. PubMed ID: 6407277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal absorption in lysinuric protein intolerance: impaired for diamino acids, normal for citrulline.
    Rajantie J; Simell O; Perheentupa J
    Gut; 1980 Jun; 21(6):519-24. PubMed ID: 6776014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrient intake in lysinuric protein intolerance.
    Tanner LM; Näntö-Salonen K; Venetoklis J; Kotilainen S; Niinikoski H; Huoponen K; Simell O
    J Inherit Metab Dis; 2007 Oct; 30(5):716-21. PubMed ID: 17588131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocitrullinuria and homoargininuria in hyperargininaemia.
    Kato T; Sano M; Mizutani N; Hayakawa C
    J Inherit Metab Dis; 1988; 11(3):261-5. PubMed ID: 2466169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine deficiency and L-carnitine supplementation in lysinuric protein intolerance.
    Tanner LM; Näntö-Salonen K; Rashed MS; Kotilainen S; Aalto M; Venetoklis J; Niinikoski H; Huoponen K; Simell O
    Metabolism; 2008 Apr; 57(4):549-54. PubMed ID: 18328359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysinuric protein intolerance presenting as childhood osteoporosis. Clinical and skeletal response to citrulline therapy.
    Carpenter TO; Levy HL; Holtrop ME; Shih VE; Anast CS
    N Engl J Med; 1985 Jan; 312(5):290-4. PubMed ID: 3917550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.